Viewing StudyNCT00301951



Ignite Creation Date: 2024-05-05 @ 4:44 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00301951
Status: COMPLETED
Last Update Posted: 2017-10-12
First Post: 2006-03-09

Brief Title: Low-Dose Fludarabine Busulfan and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
Sponsor: University of California San Francisco
Organization: University of California San Francisco

Organization Data

Organization: University of California San Francisco
Class: OTHER
Study ID: CDR0000465362
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of California San Francisco
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH